BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 28619516)

  • 1. The inner blood-retinal barrier: Cellular basis and development.
    Díaz-Coránguez M; Ramos C; Antonetti DA
    Vision Res; 2017 Oct; 139():123-137. PubMed ID: 28619516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-retinal barrier.
    Cunha-Vaz J; Bernardes R; Lobo C
    Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
    Klaassen I; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium.
    Xia T; Rizzolo LJ
    Vision Res; 2017 Oct; 139():72-81. PubMed ID: 28347688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats.
    Barber AJ; Antonetti DA
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5410-6. PubMed ID: 14638745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of diabetic macular oedema].
    Krohne TU; Fauser S; Kirchhof B; Joussen AM
    Klin Monbl Augenheilkd; 2003 Aug; 220(8):521-5. PubMed ID: 12953153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt Signaling in Inner Blood-Retinal Barrier Maintenance.
    Yemanyi F; Bora K; Blomfield AK; Wang Z; Chen J
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    J Ocul Pharmacol Ther; 1995; 11(3):469-87. PubMed ID: 8590278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.
    Kaur C; Foulds WS; Ling EA
    Prog Retin Eye Res; 2008 Nov; 27(6):622-47. PubMed ID: 18940262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy.
    Gardner TW
    Trans Am Ophthalmol Soc; 1995; 93():583-621. PubMed ID: 8719694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cell communication in diabetic retinopathy.
    Roy S; Kim D; Lim R
    Vision Res; 2017 Oct; 139():115-122. PubMed ID: 28583293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The blood-retina barrier and blood-aqueous humor barrier in type I diabetic patients without retinopathy. Determination of permeability using fluorophotometry and laser flare measurements].
    Schalnus R; Ohrloff C
    Klin Monbl Augenheilkd; 1993 Apr; 202(4):281-7. PubMed ID: 8331884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.